These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine. Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818 [TBL] [Abstract][Full Text] [Related]
6. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus. Bennett AM; Lescott T; Phillpotts RJ Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402 [TBL] [Abstract][Full Text] [Related]
7. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206 [TBL] [Abstract][Full Text] [Related]
8. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
9. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821 [TBL] [Abstract][Full Text] [Related]
11. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. Davis NL; Brown KW; Johnston RE J Virol; 1996 Jun; 70(6):3781-7. PubMed ID: 8648713 [TBL] [Abstract][Full Text] [Related]
13. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396 [TBL] [Abstract][Full Text] [Related]
14. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162 [TBL] [Abstract][Full Text] [Related]
15. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054 [TBL] [Abstract][Full Text] [Related]
17. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine. Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379 [TBL] [Abstract][Full Text] [Related]
18. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV). Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B J Virol Methods; 2010 Feb; 163(2):424-32. PubMed ID: 19903494 [TBL] [Abstract][Full Text] [Related]
19. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. Jahrling PB; Stephenson EH J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512 [TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV. Phillpotts RJ; Lescott TL; Jacobs SC Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]